Cannabidiol (CBD) in Clinical Care

Excerpt

This activity focuses on cannabidiol's (CBD) role in managing refractory epilepsy. Participants will explore indications, actions, and contraindications pertinent to CBD's efficacy in managing Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. This discussion also thoroughly reviews CBD's mechanism of action, adverse event profile, and ongoing research trials involving this drug. Additionally, understanding CBD's pharmacology helps healthcare professionals to tailor treatment plans to individual patient needs. Enhancing patient care and optimizing outcomes in epilepsy, neuropathic pain, and anxiety disorders requires emphasis on the critical role of the interprofessional healthcare team in overseeing CBD therapy.